Programming - Hypertension Scientific Sessions
Marriott Baltimore Waterfront | Baltimore, Maryland
Hypertension 2025 Schedule-at-a-Glance
Time | Activity |
---|---|
6:00 pm to 7:00 pm | Hypertension Journal Meet the Editors Networking Event |
7:00 pm to 9:00 pm | Opening Reception and Networking Session |
Time | Activity |
---|---|
7:30 am to 8:00 am | Welcome and Opening Remarks |
8:00 am to 10:00 am | Session 1 8:00 to 8:35 8:35 to 9:35 9:35 to 10:00 |
10:00 am to 10:30 am | Break |
10:30 am to 12:00 pm | Session 2 Concurrent Sessions A, B and C Invited Lectures followed by Oral Abstract Presentations |
12:00 pm to 1:00 pm | Session 3 Meet the Guidelines Keynote Speaker and Panel Networking Event |
1:00 pm to 1:30 pm | Sponsored Learning Studio Astra Zeneca |
1:30 pm to 3:00 pm | Session 4
1:30 to 2:00 2:00 to 3:00 |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm | Session 5 Concurrent Session A & B Concurrent C 3:30 to 4:30 p.m. AI in Hypertension Management: Game-Changer or Hype? Cuffless BP Measurement Devices: Are We Ready to Embrace Them? Debate: I'm All In for AI in Hypertension Management: The Future Is Now! Debate: AI in Hypertension Management? Let's Pump the Brakes! Panel Discussants 4:30 to 5:30 p.m. Key Takeaways from AHA Statement: Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care Mastering Antepartum BP Management: What You Need to Know Postpartum Hypertension Management: Optimizing Care and Outcomes Hypertensive Disorders of Pregnancy: What to Keep in Mind for the Long Game Panelists: |
5:30 pm to 7:00 pm | Poster Session 1
TAC Poster Session/Competition and Reception |
Time | Activity |
---|---|
7:00 am to 8:00 am | Session 6 Inside the AHA's Research Enterprise: Grant Funding and Other Opportunities |
7:30 am to 8:00 am | Sponsored Learning Studio Recor Medical |
8:00 am to 9:00 am |
Session 7 Speakers: |
9:00 am to 10:30 am | Poster Session 2 With Breakfast Reception |
10:30 am to 12:00 pm |
Session 8 Concurrent Session C |
12:00 pm to 1:30 pm | Session 9 CHAMP Lunch Event |
12:30 pm to 1:30 pm | Sponsored Learning Studio Medtronic |
1:30 pm to 3:00 pm |
Session 10 Concurrent C Partial list of presenters: Panelists: |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm | Session 11 Annual Hypertension Awards Session Includes:
|
5:30 pm to 6:30 pm |
Session 12 |
7:00 pm to 10:00 pm | Trainee Advocacy Mixer Event |
Time | Activity |
---|---|
7:30 am to 9:00 am | Session 13
7:30 to 8:00 8:00 to 9:00 |
9:00 am to 10:00 am |
Session 14 Concurrent C Combining Epithelial Sodium Channel Inhibitor and Mineralocorticoid Receptor Antagonist: Targeted Therapy for Resistant Hypertension in the Young Two cases in Pregnancy: Pheochromocytoma and Paraganglioma |
10:00 am to 10:30 am | Break |
10:30 am to 12:00 pm | Session 15 Concurrent A, B and C Invited Lectures followed by Oral Abstract Presentations |
12:00 pm to 12:30 pm | Sponsored Learning Studio Corcept Therapeutics |
1:00 pm to 1:30 pm | Sponsored Learning Studio Mineralys Therapeutics |
12:00 pm to 1:30 pm | Lunch on Your Own |
1:30 pm to 3:00 pm |
Session 16 Concurrent Session C Hypertension Across the Lifespan The Importance of Early Life Exposures on Later Cardiovascular Health Unique Challenges in the Treatment of Hypertension in Children and Adolescence Young Adults: How to Transition from Pediatric Care Smoothly Treatment of Older Adults to Protect Brain Health |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm |
Session 17 3:30 to 4:30 4:30-5:30 Concurrent C 3:30 – 4:30 p.m. Blood Pressure Sitting, Standing or Supine: What Does it all Mean? In a World Where Everyone Measures Blood Pressure, Making Sense of the Noise Novel Community Blood Pressure Screening Environments: From Car to Kiosks Blood Pressure on the Go: Impact of Non-Rest on Blood Pressure 4:30 – 5:30 p.m. How to Implement Stress Reduction in Blood Pressure Management: Pharmocological and Non-Pharmacological Intervention Identity Re-Boot SGLT2/GLP1RAs as Blood Pressure Drugs Role of Salt Substitutes and Diet Modification in the Management of Hypertension: Can We SaSS It Up? Emerging Therapeutics for Treatment of Hypertension: New Oral and Parenteral Options |
5:45 pm to 6:15 pm | Session 18 Excellence Award for Hypertension Research Lecture |
7:00 pm to 10:00 pm | Council Awards Banquet (Ticketed Event) |
Time | Activity |
---|---|
8:00 am to 9:30 am |
Session 19 Concurrent C 19C1 Presenters: 19C2 Best Practices in Blood Pressure Measurement and Their Physiologic Rationale Be More Efficient! Quality Matters! |
9:30 am to 10:00 am | Break |
10:00 am to 11:30 am | Session 20 Concurrent Sessions A, B and C Invited lectures followed by oral abstract presentations |
11:30 am to 12:00 pm | Closing Keynote Lecture R. Ariel Gomez, MD, FAHA |
About This Meeting
Hypertension 2025 Scientific Sessions is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.
This year's programming also includes:
- Recent Advances sessions and lectures on cutting-edge science, followed by oral abstract presentations
- Clinical Science/Clinical Practice track
- Primary Care track
- Oral abstract sessions highlighting Early Career oral abstract presentations
- Networking sessions
- Trainee Advocacy Committee (TAC) Poster session and competition
- Award Lecture sessions
Learning Objectives
- Discuss recent advances and emerging experimental models in hypertension and kidney disease.
- Summarize findings from recent clinical trials and the impact on future treatment and/or management of hypertensive and kidney-related disorders.
- Describe new therapeutic options and technologies for patients with hypertension and kidney disease.
- Describe the most up-to-date clinical guideline recommendations for the prevention, diagnosis, and management of hypertension and kidney disease.